[{"id":"b8123c42-b90f-4d8a-b03b-683f5cd5c248","acronym":"","url":"https://clinicaltrials.gov/study/NCT03939234","created_at":"2021-01-18T19:23:51.682Z","updated_at":"2024-07-02T16:36:16.853Z","phase":"Phase 2","brief_title":"Peptide Vaccination With PD-L1 and PD-L2 Peptides in Untreated Chronic Lymphatic Leukemia.","source_id_and_acronym":"NCT03939234","lead_sponsor":"Lars Møller Pedersen","biomarkers":" IGH","pipe":"","alterations":" ","tags":["IGH"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e IO103 • IO120"],"overall_status":"Completed","enrollment":" Enrollment 19","initiation":"Initiation: 04/26/2019","start_date":" 04/26/2019","primary_txt":" Primary completion: 03/15/2021","primary_completion_date":" 03/15/2021","study_txt":" Completion: 03/15/2021","study_completion_date":" 03/15/2021","last_update_posted":"2022-02-21"}]